As of September 18, 2023, recent reports indicate that GE HealthCare Techs has experienced a significant increase in its short percent of float, rising by 38.22% since its last report. This increase translates to 11.32 million shares being sold short, accounting for approximately 3.11% of all regular shares available for trading. On average, it would take traders around 4.12 days to cover their short positions.
Understanding short interest is crucial as it provides insights into market sentiment surrounding a specific stock. An increase in short interest suggests that investors have adopted a more bearish outlook, while a decrease indicates a more bullish sentiment. However, it is important to note that an increase in short interest does not necessarily guarantee an imminent decline in the stock’s value.
When comparing GE HealthCare Techs’s short interest to its peers, the average short interest as a percentage of float within its peer group stands at 3.26%. On September 15th, 2023, Nasdaq reported that GE HealthCare Technologies Inc. Common Stock (GEHC) had a short interest of 6.95 million shares, equivalent to 1.78% of the float. MarketBeat further reveals that GE HealthCare Technologies’ short percent of float is 2.09%. Additionally, Fintel reports that GEHC’s short interest score is currently at 0 out of 100, with higher scores indicating a higher likelihood of a short squeeze.
It is important for investors to recognize that short interest can fluctuate over time, and it is advisable to monitor it regularly to stay informed about market sentiment towards a specific stock.
GE HealthCare Technologies Inc.
GEHC
Strong Buy
Updated on: 29/11/2023
Financial Health
Very Healthy
Debt to equity ratio: Buy
Price to earnings ratio: Strong Buy
Price to book ratio: Strong Buy
DCF: Strong Buy
ROE: Neutral
GE Healthcare (GEHC) Stock Performance and Financial Analysis: September 18, 2023
On September 18, 2023, GE Healthcare (GEHC) stock opened at $66.01, slightly lower than the previous day’s closing price of $66.46. Throughout the day, the stock traded in a range of $65.97 to $66.93. The trading volume was relatively low at 13,247, compared to the average volume of 3,346,936 over the past three months.
GEHC is a health technology company operating in the medical specialties industry. With a market capitalization of $30.2 billion, GEHC is a significant player in the sector.
In terms of financial performance, GEHC has experienced a decline in earnings growth over the past year. The earnings growth rate for the previous year was -13.89%, and for this year, it stands at -19.13%. However, there is optimism for the future, as the company is expected to see a positive earnings growth rate of +12.00% over the next five years.
The revenue growth for the previous year was +4.30%, indicating a modest increase in the company’s top line. This growth, coupled with a net profit margin of 10.35%, showcases GEHC’s ability to generate profits from its operations.
The stock’s valuation metrics provide further insights into its performance. The price-to-earnings (P/E) ratio of 18.4 suggests that investors are willing to pay $18.4 for every dollar of earnings generated by the company. The price-to-sales ratio of 1.44 indicates that the stock is trading at 1.44 times its annual sales. The price-to-book ratio of 3.22 signifies that investors are valuing the company at 3.22 times its book value.
Looking ahead, GEHC’s next reporting date is scheduled for October 26, 2023. Analysts are forecasting an earnings per share (EPS) of $0.91 for this quarter. In the previous year, the company reported annual revenue of $18.3 billion and a profit of $1.9 billion.
In conclusion, GEHC’s stock performance on September 18, 2023, showed a slight decline from the previous day’s close. The company has experienced a decline in earnings growth but is expected to see positive growth in the coming years. With a solid revenue growth rate and a healthy net profit margin, GEHC demonstrates its ability to generate profits. Investors will be eagerly awaiting the next reporting date to assess the company’s financial performance.
Promising Performances and Positive Outlook: GE Healthcare Technologies Inc (GEHC) Stock Analysis and Future Prospects
On September 18, 2023, GE Healthcare Technologies Inc (GEHC) stock showed promising performances based on the information provided by CNN Money. The 10 analysts offering 12-month price forecasts for GEHC had a median target of $91.00, with a high estimate of $99.00 and a low estimate of $78.00. This median estimate represents a significant increase of 36.47% from the last recorded price of $66.68.
The consensus among 13 polled investment analysts was to buy stock in GEHC. This rating has remained steady since August, indicating a consistent positive sentiment towards the company’s future prospects. Investors seem to have confidence in GEHC’s ability to deliver strong performance and growth in the coming months.
In terms of financials, GEHC reported earnings per share of $0.91 for the current quarter, indicating a solid performance. Additionally, the company recorded sales of $4.8 billion, reflecting a healthy revenue stream. These figures suggest that GEHC is on track to achieve its financial goals and maintain a stable financial position.
Investors can look forward to the upcoming reporting date on October 26, when GEHC will provide further insights into its financial performance and future outlook. This information can help investors make informed decisions regarding their investment in GEHC stock.
Discussion about this post